TheraRadar

PDUFA Dates: February 2027

2 FDA target action dates in February 2027. Each PDUFA date is the FDA's deadline to complete review of a drug application.

Mix: 1 NDA, 1 unspecified. Therapeutic areas: oncology.

Cullinan Therapeutics, Inc. CGEM
Zipalertinib
NSCLC with EGFR exon 20 insertion (post-platinum) Oncology
NDA
Feb 27, 2027
105 days
Details →
PALVELLA THERAPEUTICS, INC. PVLA
QTORIN 0
Feb 28, 2027
106 days
Details →